Oncternal Therapeutics raised a round of funding on July 08, 2016.
Oncternal Therapeutics, formerly Tokalas, is a clinical-stage oncology company developing therapies for both rare and common cancers by focusing on targets that are uniquely expressed within cancer ce…
